Product record
Aspirin: batches declared Not of Standard Quality
Not bannedIs Aspirin (Disprin) banned in India?Not banned. Read the answer
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts, Jan 2019 to Sep 2026
10 batches of products named "Aspirin" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test between June 2021 and September 2026. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.
Records by type
10 records linked to Aspirin in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches
| Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Batch TAS25011ALMfg Jun 2025 · Exp May 2027 | Hindustan Laboratories LimitedMaharashtra | DissolutionDissolution | Drug Testing Laboratory, Chennai-6State lab | Sep 2026 |
| Batch LPT2526188Mfg Jun 2025 · Exp May 2027 | Lannet Pharmaceuticals Pvt. Ltd | The Sample does not Comply with IP Requiremnts for the Dissolution Test.Dissolution | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab | Sep 2026 |
| Batch 240968Mfg Sep 2024 · Exp Aug 2027 | Modi AntibioticsGujarat | l]five (5) intact strips often (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2. The content of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling | FDAL, MumbaiState lab | Jul 2026 |
| Batch 250168Mfg Jan 2025 · Exp Dec 2027 | Modi AntibioticsGujarat | 1. five (5) intact strips of ten (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2 The co tent of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling | FDAL, MumbaiState lab | Jul 2026 |
| Batch T-6705Mfg Jul 2025 · Exp Jun 2027 | Jackson Laboratories Pvt.Ltd 22-24Punjab | The sample is not of standard quality for the reason stated under Description of the tablets.Description | RDTL, GuwahatiCDSCO lab | Feb 2026 |
| Batch 241271Mfg Dec 2024 · Exp Nov 2027 | Modi AntibioticsGujarat | 1) The Sample does not Comply for Description as White Circular Powdery Tablets which are too brittle in nature shows needle shaped Crystals in all the blister Packets.2) The Content of Aspirin in the Sample is less (i.e. 69.84% of Stated amount) than the IP Limits. (IP Limit - Not less than 95% and Not more than 105% of stated Amount)Description | FDA, Lab, M.S Chhatrapati Sambhaji Nagar Maharashtra StateState lab | Nov 2025 |
| Batch 240604Mfg Jun 2024 · Exp May 2027 | Modi AntibioticsGujarat | 1) The Sample does not Comply for Description as White Circular Powdery Tablets which are too brittle in nature shows needle shaped Crystals in all the blister Packets. 2)The Sample does not give IP Identification for the Presence of Aspirin. 3) The Sample gives additional Identification for the Presence of Salicylic Acid. 4) Found Content of Salicylic Acid in the Sample is 73.68 mg/Tablet.Description | FDA, Lab, M.S Chhatrapati Sambhaji Nagar Maharashtra StateState lab | Nov 2025 |
| Batch G/25/1739Mfg Apr 2025 · Exp Mar 2027 | Modi AntibioticGujarat | Description and related substances.Description | FDAL, MaharashtraState lab | Sep 2025 |
| Batch TAS2301 0ALMfg Oct 2023 · Exp Sep 2025 | Hindustan Laboratories LimitedMaharashtra | Sample does not conform to IP Specification for Aspirin Tablets with respect to the content of Aspirin.Other | DTL MaduraiState lab | Jan 2025 |
| Batch T-20902Mfg Nov 2019 · Exp Oct 2021 | Jackson Laboratories Pvt. LtdMaharashtra | DescriptionDescription | RDTL GuwahatiState lab | Jun 2021 |
How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of September 2026. Check any batch number.